INSIGHTS ON ENTERPRISE SOLUTIONS
-
![GettyImages-1294339697 Engineer at computer]( "Unlocking Pharma Manufacturing with Contextualized Data")
Unlocking Pharma Manufacturing with Contextualized DataContext gives meaning to data, transforming raw numbers into actionable insights, with AI-driven tools that connect data across the manufacturing workflow.
-
![GettyImages-1483243079-doctors-data-computer-analysis-tablet-office]( "Revolutionizing Pharma Validation With AI")
Revolutionizing Pharma Validation With AIValidation in GxP environments is often the bottleneck in digital transformation—manual, repetitive, and complex. One company's Intelligent Agents are transforming that process.
-
![Accelerate And Enhance Biomanufacturing Operator Training Splash]( "Accelerate And Enhance Biomanufacturing Operator Training")
Accelerate And Enhance Biomanufacturing Operator TrainingUnlock the power of blended operator training and learn how combining digital tools with hands-on instruction reduces errors, boosts retention, and empowers your workforce for real-world production success.
-
![GettyImages-513110674 lab, research, sample, vial]( "Navigating CMC Regulation For Plasmid DNA In Gene Therapy")
Navigating CMC Regulation For Plasmid DNA In Gene TherapyExplore how evolving regulatory pathways and CMC innovation are shaping the future of gene therapy and viral vector production, plus what to consider when selecting a CDMO partner.
-
An Extended Kinetics Study Of AAV Viral Vector Production5/28/2025
This study aims to explore the kinetics of capsid formation and impurity profiles over time, offering insights that can inform future process improvements.
-
Taking A Look At AAV Production Using HEK293 In A Perfusion Process5/28/2025
Discover a scalable, cost-effective solution for gene therapy manufacturing with VintaProcess™ — featuring VintaCell™, VintaFect™, and fixed-bed bioreactor technology.
-
The Evolution Of AAV Production: Scaling Through Nature Instead Of Brute Force5/28/2025
This study evaluates the performance and productivity of VintaProcess in addressing the persistent manufacturing challenges in AAV gene therapy production.
-
Innovations In Hybridoma-Based Therapeutic Antibody Discovery Against Type 1 Transmembrane Proteins5/23/2025
Leverage the PentaMice®-powered hybridoma discovery and humanization platform to develop high-affinity, cross-reactive monoclonal antibodies against Type I transmembrane protein targets.
ENTERPRISE SOLUTIONS
-
![GettyImages-1434627610 lab, manufacturing]( "End-To-End Clinical And Commercial Manufacturing Support")
Partner with Abzena’s cGMP manufacturing facility to ensure seamless, high-quality scale-up from clinical development to commercial production of your biologics.
-
![GettyImages-2032712502-scientists-tablet-training-labratory]( "Operator Training Programs")
Build a stronger biomanufacturing workforce with flexible, expert-led operator training. Empower your team with essential process knowledge, technology insights, and hands-on equipment skills anytime, anywhere, and at their own pace.
-
![Lab science API chemistry 450x300]( "Unparalleled Efficiency And Precision In HPAPIs")
Our state-of-the-art HPAPI manufacturing facilities offer you an exceptional experience, setting a new standard for quality and efficiency in the industry.
-
![GettyImages-1013103082 antibodies, cell]( "Pull Your Fill/Finish Line Closer")
By partnering with us, you gain access to our unique, interconnected network, purpose-built to overcome the breakpoints common in traditional manufacturing models.
-
![GettyImages-2098817477-vaccine-needle-syringe-gloved-hands-laboratory]( "Excellence In Every Injection.")
We don’t just manufacture sterile injectables — we provide trusted partnership, operational excellence, and a deep commitment to getting life-saving therapies to patients safely, reliably, and on time.
